{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T17:25:57Z","timestamp":1790702757408,"version":"4.1.0"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,30]],"date-time":"2024-12-30T00:00:00Z","timestamp":1735516800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,12,30]],"date-time":"2024-12-30T00:00:00Z","timestamp":1735516800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>This study examined the incidence, characteristics, and risk factors of new gastrointestinal disorders (GID) associated with SARS-CoV-2 infection up to 3.5 years post-infection. This retrospective study included 35,102 COVID-19 patients and 682,594 contemporary non-COVID-19 patients without past medical history of GID (controls) from the Montefiore Health System in the Bronx (3\/1\/2020 to 7\/31\/2023). Comparisons were made with unmatched and propensity-matched (1:2) controls. The primary outcome was new GID which included peptic ulcer, inflammatory bowel disease, irritable bowel syndrome, diverticulosis, diverticulitis, and biliary disease. Multivariate Cox proportional hazards model analysis was performed with adjustment for covariates. There were 2,228 (6.34%) COVID-19 positive patients who developed new GID compared to 38,928 (5.70%) controls. COVID-19 patients had an elevated risk of developing new GID (adjusted HR\u2009=\u20091.18 (95% CI 1.12\u20131.25) compared to propensity-matched controls, after adjusting for confounders that included smoking, obesity, diabetes, hypertension. These findings underscore the need for additional research and follow-up of at-risk individuals for developing GID post infection.<\/jats:p>","DOI":"10.1038\/s41598-024-83232-7","type":"journal-article","created":{"date-parts":[[2024,12,30]],"date-time":"2024-12-30T20:21:16Z","timestamp":1735590076000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["New-onset gastrointestinal disorders in COVID-19 patients 3.5 years post-infection in the inner-city population in the Bronx"],"prefix":"10.1038","volume":"14","author":[{"given":"Sagar","family":"Changela","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samad","family":"Ashraf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin Y.","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin E.","family":"Duong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonya","family":"Henry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen H.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim Q.","family":"Duong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,30]]},"reference":[{"key":"83232_CR1","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","volume":"395","author":"C Huang","year":"2020","unstructured":"Huang, C. et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 395, 497\u2013506. https:\/\/doi.org\/10.1016\/S0140-6736(20)30183-5 (2020).","journal-title":"Lancet"},{"key":"83232_CR2","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1001\/jama.2020.1585","volume":"323","author":"D Wang","year":"2020","unstructured":"Wang, D. et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA 323, 1061\u20131069. https:\/\/doi.org\/10.1001\/jama.2020.1585 (2020).","journal-title":"JAMA"},{"key":"83232_CR3","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1001\/jamacardio.2020.1017","volume":"5","author":"T Guo","year":"2020","unstructured":"Guo, T. et al. Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19). JAMA Cardiol. 5, 811\u2013818. https:\/\/doi.org\/10.1001\/jamacardio.2020.1017 (2020).","journal-title":"JAMA Cardiol."},{"key":"83232_CR4","doi-asserted-by":"publisher","first-page":"39","DOI":"10.55729\/2000-9666.1145","volume":"13","author":"B Hossain","year":"2023","unstructured":"Hossain, B. et al. Prevalence and impact of gastrointestinal manifestations in COVID-19 patients: A systematic review. J. community Hosp. Intern. Med. Perspect. 13, 39\u201354. https:\/\/doi.org\/10.55729\/2000-9666.1145 (2023).","journal-title":"J. community Hosp. Intern. Med. Perspect."},{"key":"83232_CR5","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1093\/trstmh\/trab042","volume":"115","author":"JC Kariyawasam","year":"2021","unstructured":"Kariyawasam, J. C., Jayarajah, U., Riza, R., Abeysuriya, V. & Seneviratne, S. L. Gastrointestinal manifestations in COVID-19. Trans. R. Soc. Trop. Med. Hyg. 115, 1362\u20131388. https:\/\/doi.org\/10.1093\/trstmh\/trab042 (2021).","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"83232_CR6","doi-asserted-by":"publisher","first-page":"13308","DOI":"10.1038\/s41598-021-92740-9","volume":"11","author":"GJ Britton","year":"2021","unstructured":"Britton, G. J. et al. Limited intestinal inflammation despite diarrhea, fecal viral RNA and SARS-CoV-2-specific IgA in patients with acute COVID-19. Sci. Rep. 11, 13308. https:\/\/doi.org\/10.1038\/s41598-021-92740-9 (2021).","journal-title":"Sci. Rep."},{"key":"83232_CR7","doi-asserted-by":"publisher","first-page":"916","DOI":"10.14309\/ajg.0000000000000664","volume":"115","author":"C Han","year":"2020","unstructured":"Han, C. et al. Digestive symptoms in COVID-19 patients with mild disease severity: clinical presentation, Stool Viral RNA Testing, and Outcomes. Am. J. Gastroenterol. 115, 916\u2013923. https:\/\/doi.org\/10.14309\/ajg.0000000000000664 (2020).","journal-title":"Am. J. Gastroenterol."},{"key":"83232_CR8","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1002\/path.1570","volume":"203","author":"I Hamming","year":"2004","unstructured":"Hamming, I. et al. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J. Pathol. 203, 631\u2013637. https:\/\/doi.org\/10.1002\/path.1570 (2004).","journal-title":"J. Pathol."},{"key":"83232_CR9","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s11684-020-0754-0","volume":"14","author":"X Zou","year":"2020","unstructured":"Zou, X. et al. Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection. Front. Med. 14, 185\u2013192. https:\/\/doi.org\/10.1007\/s11684-020-0754-0 (2020).","journal-title":"Front. Med."},{"key":"83232_CR10","doi-asserted-by":"publisher","unstructured":"Xu, J. et al. Digestive symptoms of COVID-19 and expression of ACE2 in digestive tract organs. Cell. Death Discov. . 6 https:\/\/doi.org\/10.1038\/s41420-020-00307-w (2020).","DOI":"10.1038\/s41420-020-00307-w"},{"key":"83232_CR11","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1186\/s12985-015-0448-4","volume":"12","author":"L Minodier","year":"2015","unstructured":"Minodier, L. et al. Prevalence of gastrointestinal symptoms in patients with influenza, clinical significance, and pathophysiology of human influenza viruses in faecal samples: What do we know? Virol. J. 12, 215. https:\/\/doi.org\/10.1186\/s12985-015-0448-4 (2015).","journal-title":"Virol. J."},{"key":"83232_CR12","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1186\/s12879-017-2823-9","volume":"17","author":"L Minodier","year":"2017","unstructured":"Minodier, L. et al. Clinical and virological factors associated with gastrointestinal symptoms in patients with acute respiratory infection: A two-year prospective study in general practice medicine. BMC Infect. Dis. 17, 729. https:\/\/doi.org\/10.1186\/s12879-017-2823-9 (2017).","journal-title":"BMC Infect. Dis."},{"key":"83232_CR13","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.celrep.2019.05.105","volume":"28","author":"KC Bradley","year":"2019","unstructured":"Bradley, K. C. et al. Microbiota-driven tonic interferon signals in lung stromal cells protect from influenza virus infection. Cell. Rep. 28, 245\u2013256e244. https:\/\/doi.org\/10.1016\/j.celrep.2019.05.105 (2019).","journal-title":"Cell. Rep."},{"key":"83232_CR14","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1097\/01.inf.0000245097.95543.11","volume":"25","author":"SH Wootton","year":"2006","unstructured":"Wootton, S. H., Scheifele, D. W., Mak, A., Petric, M. & Skowronski, D. M. Detection of human influenza virus in the stool of children. Pediatr. Infect. Dis. J. 25, 1194\u20131195. https:\/\/doi.org\/10.1097\/01.inf.0000245097.95543.11 (2006).","journal-title":"Pediatr. Infect. Dis. J."},{"key":"83232_CR15","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.jcv.2009.06.011","volume":"45","author":"MC Chan","year":"2009","unstructured":"Chan, M. C., Lee, N., Chan, P. K., Leung, T. F. & Sung, J. J. Fecal detection of influenza A virus in patients with concurrent respiratory and gastrointestinal symptoms. J. Clin. virology: official publication Pan Am. Soc. Clin. Virol. 45, 208\u2013211. https:\/\/doi.org\/10.1016\/j.jcv.2009.06.011 (2009).","journal-title":"J. Clin. virology: official publication Pan Am. Soc. Clin. Virol."},{"key":"83232_CR16","doi-asserted-by":"publisher","first-page":"e136","DOI":"10.1017\/s0950268822001200","volume":"150","author":"E Austhof","year":"2022","unstructured":"Austhof, E. et al. Persisting gastrointestinal symptoms and post-infectious irritable bowel syndrome following SARS-CoV-2 infection: Results from the Arizona CoVHORT. Epidemiol. Infect. 150, e136. https:\/\/doi.org\/10.1017\/s0950268822001200 (2022).","journal-title":"Epidemiol. Infect."},{"key":"83232_CR17","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1038\/s41467-023-36223-7","volume":"14","author":"E Xu","year":"2023","unstructured":"Xu, E., Xie, Y. & Al-Aly, Z. Long-term gastrointestinal outcomes of COVID-19. Nat. Commun. 14, 983. https:\/\/doi.org\/10.1038\/s41467-023-36223-7 (2023).","journal-title":"Nat. Commun."},{"key":"83232_CR18","doi-asserted-by":"publisher","first-page":"e33252","DOI":"10.7759\/cureus.33252","volume":"15","author":"C Karime","year":"2023","unstructured":"Karime, C., Travers, P., Ouni, A. & Francis, D. Association between coronavirus disease 2019 and acute complicated diverticulitis. Cureus 15, e33252. https:\/\/doi.org\/10.7759\/cureus.33252 (2023).","journal-title":"Cureus"},{"key":"83232_CR19","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/j.cgh.2022.10.015","volume":"21","author":"R Golla","year":"2023","unstructured":"Golla, R. et al. Long-term gastrointestinal sequelae following COVID-19: A prospective follow-up cohort study. Clin. Gastroenterol. hepatology: official Clin. Pract. J. Am. Gastroenterological Association. 21, 789\u2013796e781. https:\/\/doi.org\/10.1016\/j.cgh.2022.10.015 (2023).","journal-title":"Clin. Gastroenterol. hepatology: official Clin. Pract. J. Am. Gastroenterological Association"},{"key":"83232_CR20","doi-asserted-by":"publisher","unstructured":"Iosifescu, A. L., Hoogenboom, W. S., Buczek, A. J., Fleysher, R. & Duong, T. Q. New-onset and persistent neurological and psychiatric sequelae of COVID-19 compared to influenza: A retrospective cohort study in a large New York City healthcare network. Int. J. Methods Psychiatr. Res. 31, e doi: (1914). https:\/\/doi.org\/10.1002\/mpr.1914 (2022).","DOI":"10.1002\/mpr.1914"},{"key":"83232_CR21","doi-asserted-by":"publisher","first-page":"3014","DOI":"10.3324\/haematol.2021.279222","volume":"106","author":"WS Hoogenboom","year":"2021","unstructured":"Hoogenboom, W. S. et al. Individuals with sickle cell disease and sickle cell trait demonstrate no increase in mortality or critical illness from COVID-19\u2014A fifteen hospital observational study in the Bronx, New York. Haematologica 106, 3014\u20133016. https:\/\/doi.org\/10.3324\/haematol.2021.279222 (2021).","journal-title":"Haematologica"},{"key":"83232_CR22","doi-asserted-by":"publisher","unstructured":"Xu, A. Y., Wang, S. H. & Duong, T. Q. Patients with prediabetes are at greater risk of developing diabetes 5 months postacute SARS-CoV-2 infection: A retrospective cohort study. BMJ Open. Diabetes Res. Care. 11 https:\/\/doi.org\/10.1136\/bmjdrc-2022-003257 (2023).","DOI":"10.1136\/bmjdrc-2022-003257"},{"key":"83232_CR23","doi-asserted-by":"publisher","unstructured":"Lu, J. Q. et al. Clinical predictors of acute cardiac injury and normalization of troponin after hospital discharge from COVID-19. EBioMedicine 103821 https:\/\/doi.org\/10.1016\/j.ebiom.2022.103821 (2022).","DOI":"10.1016\/j.ebiom.2022.103821"},{"key":"83232_CR24","doi-asserted-by":"publisher","first-page":"647023","DOI":"10.3389\/fmed.2021.647023","volume":"8","author":"JY Lu","year":"2021","unstructured":"Lu, J. Y., Babatsikos, I., Fisher, M. C., Hou, W. & Duong, T. Q. Longitudinal clinical profiles of hospital vs. community-acquired acute kidney injury in COVID-19. Front. Med.. 8, 647023. https:\/\/doi.org\/10.3389\/fmed.2021.647023 (2021).","journal-title":"Front. Med. (Lausanne)"},{"key":"83232_CR25","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfad020","author":"JY Lu","year":"2023","unstructured":"Lu, J. Y. et al. Long-term outcomes of COVID-19 survivors with hospital AKI: Association with time to recovery from AKI. Nephrol. Dial Transpl. https:\/\/doi.org\/10.1093\/ndt\/gfad020 (2023).","journal-title":"Nephrol. Dial Transpl."},{"key":"83232_CR26","doi-asserted-by":"publisher","first-page":"e15277","DOI":"10.1016\/j.heliyon.2023.e15277","volume":"9","author":"JY Lu","year":"2023","unstructured":"Lu, J. Y. et al. Characteristics of COVID-19 patients with multiorgan injury across the pandemic in a large academic health system in the Bronx, New York. Heliyon 9, e15277. https:\/\/doi.org\/10.1016\/j.heliyon.2023.e15277 (2023).","journal-title":"Heliyon"},{"key":"83232_CR27","doi-asserted-by":"publisher","first-page":"104487","DOI":"10.1016\/j.ebiom.2023.104487","volume":"90","author":"JY Lu","year":"2023","unstructured":"Lu, J. Y. et al. Incidence of new-onset in-hospital and persistent diabetes in COVID-19 patients: Comparison with influenza. EBioMedicine 90, 104487. https:\/\/doi.org\/10.1016\/j.ebiom.2023.104487 (2023).","journal-title":"EBioMedicine"},{"key":"83232_CR28","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1161\/HYPERTENSIONAHA.123.21174","volume":"80","author":"V Zhang","year":"2023","unstructured":"Zhang, V., Fisher, M., Hou, W., Zhang, L. & Duong, T. Q. Incidence of new-onset hypertension post-COVID-19: Comparison With Influenza. Hypertension 80, 2135\u20132148. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.123.21174 (2023).","journal-title":"Hypertension"},{"key":"83232_CR29","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s15010-021-01646-1","volume":"50","author":"JY Lu","year":"2022","unstructured":"Lu, J. Y., Hou, W. & Duong, T. Q. Longitudinal prediction of hospital-acquired acute kidney injury in COVID-19: A two-center study. Infection 50, 109\u2013119. https:\/\/doi.org\/10.1007\/s15010-021-01646-1 (2022).","journal-title":"Infection"},{"key":"83232_CR30","doi-asserted-by":"publisher","first-page":"17972","DOI":"10.1038\/s41598-022-22741-9","volume":"12","author":"JY Lu","year":"2022","unstructured":"Lu, J. Y. et al. Clinical predictors of recovery of COVID-19 associated-abnormal liver function test 2 months after hospital discharge. Sci. Rep. 12, 17972. https:\/\/doi.org\/10.1038\/s41598-022-22741-9 (2022).","journal-title":"Sci. Rep."},{"key":"83232_CR31","doi-asserted-by":"publisher","DOI":"10.1111\/dom.15120","author":"K Dell\u2019Aquila","year":"2023","unstructured":"Dell\u2019Aquila, K. et al. Incidence, characteristics, risk factors and outcomes of diabetic ketoacidosis in COVID-19 patients: Comparison with influenza and pre-pandemic data. Diabetes Obes. Metab. https:\/\/doi.org\/10.1111\/dom.15120 (2023).","journal-title":"Diabetes Obes. Metab."},{"key":"83232_CR32","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1111\/ejh.14058","volume":"111","author":"A Feit","year":"2023","unstructured":"Feit, A. et al. Long-term clinical outcomes and healthcare utilization of sickle cell disease patients with COVID-19: A 2.5-year follow-up study. Eur. J. Haematol. 111, 636\u2013643. https:\/\/doi.org\/10.1111\/ejh.14058 (2023).","journal-title":"Eur. J. Haematol."},{"key":"83232_CR33","doi-asserted-by":"publisher","first-page":"119","DOI":"10.3390\/diagnostics13010119","volume":"13","author":"A Eligulashvili","year":"2022","unstructured":"Eligulashvili, A. et al. COVID-19 Patients in the COVID-19 recovery and engagement (CORE) Clinics in the Bronx. Diagnostics. 13, 119. https:\/\/doi.org\/10.3390\/diagnostics13010119 (2022).","journal-title":"Diagnostics (Basel)"},{"key":"83232_CR34","doi-asserted-by":"publisher","first-page":"798897","DOI":"10.3389\/fcvm.2021.798897","volume":"8","author":"JY Lu","year":"2021","unstructured":"Lu, J. Y. et al. Outcomes of hospitalized patients with COVID-19 with acute kidney injury and acute cardiac injury. Front. Cardiovasc. Med. 8, 798897. https:\/\/doi.org\/10.3389\/fcvm.2021.798897 (2021).","journal-title":"Front. Cardiovasc. Med."},{"key":"83232_CR35","doi-asserted-by":"publisher","first-page":"7743","DOI":"10.1038\/s41598-024-58430-y","volume":"14","author":"A Eligulashvili","year":"2024","unstructured":"Eligulashvili, A. et al. Patients with unmet social needs are at higher risks of developing severe long COVID-19 symptoms and neuropsychiatric sequela. Sci. Rep. 14, 7743. https:\/\/doi.org\/10.1038\/s41598-024-58430-y (2024).","journal-title":"Sci. Rep."},{"key":"83232_CR36","doi-asserted-by":"publisher","first-page":"e1004263","DOI":"10.1371\/journal.pmed.1004263","volume":"21","author":"A Eligulashvili","year":"2024","unstructured":"Eligulashvili, A. et al. Long-term outcomes of hospitalized patients with SARS-CoV-2\/COVID-19 with and without neurological involvement: 3-year follow-up assessment. PLoS Med. 21, e1004263. https:\/\/doi.org\/10.1371\/journal.pmed.1004263 (2024).","journal-title":"PLoS Med."},{"key":"83232_CR37","doi-asserted-by":"publisher","first-page":"105613","DOI":"10.1016\/j.msard.2024.105613","volume":"86","author":"R Hadidchi","year":"2024","unstructured":"Hadidchi, R. et al. SARS-CoV-2 infection increases long-term multiple sclerosis disease activity and all-cause mortality in an underserved inner-city population. Mult Scler. Relat. Disord. 86, 105613. https:\/\/doi.org\/10.1016\/j.msard.2024.105613 (2024).","journal-title":"Mult Scler. Relat. Disord"},{"key":"83232_CR38","doi-asserted-by":"publisher","first-page":"5368","DOI":"10.1111\/dom.15900","volume":"26","author":"S Mehrotra-Varma","year":"2024","unstructured":"Mehrotra-Varma, S. et al. Patients with type 1 diabetes are at elevated risk of developing new hypertension, chronic kidney disease and diabetic ketoacidosis after COVID-19: Up to 40 months\u2019 follow-up. Diabetes Obes. Metab. 26, 5368\u20135375. https:\/\/doi.org\/10.1111\/dom.15900 (2024).","journal-title":"Diabetes Obes. Metab."},{"key":"83232_CR39","doi-asserted-by":"publisher","first-page":"e0303151","DOI":"10.1371\/journal.pone.0303151","volume":"19","author":"T Peng","year":"2024","unstructured":"Peng, T. et al. Incidence, characteristics, and risk factors of new liver disorders 3.5 years post COVID-19 pandemic in the Montefiore Health System in Bronx. PLoS One. 19, e0303151. https:\/\/doi.org\/10.1371\/journal.pone.0303151 (2024).","journal-title":"PLoS One"},{"key":"83232_CR40","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1136\/gutjnl-2021-324280","volume":"71","author":"CCL Cheung","year":"2022","unstructured":"Cheung, C. C. L. et al. Residual SARS-CoV-2 viral antigens detected in GI and hepatic tissues from five recovered patients with COVID-19. Gut 71, 226\u2013229. https:\/\/doi.org\/10.1136\/gutjnl-2021-324280 (2022).","journal-title":"Gut"},{"key":"83232_CR41","doi-asserted-by":"publisher","unstructured":"Hawkings, M. J. et al. A Systematic review of the prevalence of persistent gastrointestinal symptoms and incidence of new gastrointestinal illness after acute SARS-CoV-2 infection. Viruses 15 https:\/\/doi.org\/10.3390\/v15081625 (2023).","DOI":"10.3390\/v15081625"},{"key":"83232_CR42","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1056\/NEJMoa2403211","volume":"391","author":"Y Xie","year":"2024","unstructured":"Xie, Y., Choi, T. & Al-Aly, Z. Postacute Sequelae of SARS-CoV-2 infection in the pre-delta, delta, and omicron eras. N Engl. J. Med. 391, 515\u2013525. https:\/\/doi.org\/10.1056\/NEJMoa2403211 (2024).","journal-title":"N Engl. J. Med."},{"key":"83232_CR43","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1126\/science.abc1669","volume":"369","author":"MM Lamers","year":"2020","unstructured":"Lamers, M. M. et al. SARS-CoV-2 productively infects human gut enterocytes. Sci. (New York N Y). 369, 50\u201354. https:\/\/doi.org\/10.1126\/science.abc1669 (2020).","journal-title":"Sci. (New York N Y)"},{"key":"83232_CR44","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1097\/cm9.0000000000001439","volume":"134","author":"W Lin","year":"2021","unstructured":"Lin, W. et al. Single-cell analysis of angiotensin-converting enzyme II expression in human kidneys and bladders reveals a potential route of 2019 novel coronavirus infection. Chin. Med. J. 134, 935\u2013943. https:\/\/doi.org\/10.1097\/cm9.0000000000001439 (2021).","journal-title":"Chin. Med. J."},{"key":"83232_CR45","doi-asserted-by":"publisher","unstructured":"Saviano, A. et al. Intestinal damage, inflammation and microbiota alteration during COVID-19 Infection. Biomedicines 11 https:\/\/doi.org\/10.3390\/biomedicines11041014 (2023).","DOI":"10.3390\/biomedicines11041014"},{"key":"83232_CR46","doi-asserted-by":"publisher","unstructured":"Khreefa, Z., Barbier, M. T., Koksal, A. R., Love, G. & Del Valle, L. Pathogenesis and mechanisms of SARS-CoV-2 infection in the intestine, liver, and pancreas. Cells 12, doi: (2023). https:\/\/doi.org\/10.3390\/cells12020262","DOI":"10.3390\/cells12020262"},{"key":"83232_CR47","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.bbrc.2020.03.044","volume":"526","author":"F Qi","year":"2020","unstructured":"Qi, F., Qian, S., Zhang, S. & Zhang, Z. Single cell RNA sequencing of 13 human tissues identify cell types and receptors of human coronaviruses. Biochem. Biophys. Res. Commun. 526, 135\u2013140. https:\/\/doi.org\/10.1016\/j.bbrc.2020.03.044 (2020).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"83232_CR48","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.ajpath.2020.08.009","volume":"191","author":"JN Gustine","year":"2021","unstructured":"Gustine, J. N. & Jones, D. Immunopathology of Hyperinflammation in COVID-19. Am. J. Pathol. 191, 4\u201317. https:\/\/doi.org\/10.1016\/j.ajpath.2020.08.009 (2021).","journal-title":"Am. J. Pathol."},{"key":"83232_CR49","doi-asserted-by":"publisher","first-page":"113810","DOI":"10.1016\/j.biopha.2022.113810","volume":"155","author":"PJ Ma","year":"2022","unstructured":"Ma, P. J., Wang, M. M. & Wang, Y. Gut microbiota: A new insight into lung diseases. Biomed. pharmacotherapy Biomedecine pharmacotherapie. 155, 113810. https:\/\/doi.org\/10.1016\/j.biopha.2022.113810 (2022).","journal-title":"Biomed. pharmacotherapy = Biomedecine pharmacotherapie"},{"key":"83232_CR50","doi-asserted-by":"publisher","first-page":"765965","DOI":"10.3389\/fimmu.2021.765965","volume":"12","author":"I Hussain","year":"2021","unstructured":"Hussain, I., Cher, G. L. Y., Abid, M. A. & Abid, M. B. Role of gut microbiome in COVID-19: An insight into pathogenesis and therapeutic potential. Front. Immunol. 12, 765965. https:\/\/doi.org\/10.3389\/fimmu.2021.765965 (2021).","journal-title":"Front. Immunol."},{"key":"83232_CR51","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.4254\/wjh.v13.i12.1850","volume":"13","author":"MF Law","year":"2021","unstructured":"Law, M. F., Ho, R., Law, K. W. T. & Cheung, C. K. M. Gastrointestinal and hepatic side effects of potential treatment for COVID-19 and vaccination in patients with chronic liver diseases. World J. Hepatol. 13, 1850\u20131874. https:\/\/doi.org\/10.4254\/wjh.v13.i12.1850 (2021).","journal-title":"World J. Hepatol."},{"key":"83232_CR52","doi-asserted-by":"crossref","unstructured":"Ye, Q. et al. The mechanism and treatment of gastrointestinal symptoms in patients with COVID-19. 319, G245\u2013G252 (2020).","DOI":"10.1152\/ajpgi.00148.2020"},{"key":"83232_CR53","first-page":"2418","volume":"11","author":"SD Upadhaya","year":"2021","unstructured":"Upadhaya, S. D. & Kim, I. H. The impact of weaning stress on gut health and the mechanistic aspects of several feed additives contributing to improved gut health function in weanling piglets\u2014A review. J. A. 11, 2418 (2021).","journal-title":"J. A"},{"key":"83232_CR54","doi-asserted-by":"crossref","unstructured":"Moloney, R. D., Desbonnet, L., Clarke, G., Dinan, T. G. & Cryan, J. F. J. M. g. The microbiome: Stress, health and disease. 25, 49\u201374 (2014).","DOI":"10.1007\/s00335-013-9488-5"},{"key":"83232_CR55","doi-asserted-by":"publisher","first-page":"2765","DOI":"10.1001\/jama.2008.839","volume":"300","author":"E Botteri","year":"2008","unstructured":"Botteri, E. et al. Smoking and colorectal cancer: A meta-analysis. Jama 300, 2765\u20132778 (2008).","journal-title":"Jama"},{"key":"83232_CR56","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/S0300-5089(21)00614-3","volume":"13","author":"JH KURATA","year":"1984","unstructured":"KURATA, J. H. & HAILE, B. M. Epidemiology of peptic ulcer disease. Clin. Gastroenterol. 13, 289\u2013307 (1984).","journal-title":"Clin. Gastroenterol."},{"key":"83232_CR57","unstructured":"Mahid, S. S., Minor, K. S., Soto, R. E., Hornung, C. A. & Galandiuk, S. in Mayo Clinic Proceedings. 1462\u20131471 (Elsevier)."},{"key":"83232_CR58","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1210\/er.2018-00161","volume":"40","author":"AE Bharucha","year":"2019","unstructured":"Bharucha, A. E., Kudva, Y. C. & Prichard, D. O. Diabetic gastroparesis. Endocr. Rev. 40, 1318\u20131352 (2019).","journal-title":"Endocr. Rev."},{"key":"83232_CR59","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/hep.28431","volume":"64","author":"ZM Younossi","year":"2016","unstructured":"Younossi, Z. M. et al. Global epidemiology of nonalcoholic fatty liver disease\u2014meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology 64, 73\u201384 (2016).","journal-title":"Hepatology"},{"key":"83232_CR60","doi-asserted-by":"publisher","first-page":"111297","DOI":"10.1016\/j.mehy.2024.111297","volume":"185","author":"AG Miranda","year":"2024","unstructured":"Miranda, A. G. et al. Inquiring into the collusion between two-system diseases: Potential impact of hypertension over gastroesophageal reflux disease. Med. Hypotheses. 185, 111297 (2024).","journal-title":"Med. Hypotheses"},{"key":"83232_CR61","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1007\/s10620-013-2973-6","volume":"59","author":"KW Huang","year":"2014","unstructured":"Huang, K. W. et al. Different peptic ulcer bleeding risk in chronic kidney disease and end-stage renal disease patients receiving different dialysis. Dig. Dis. Sci. 59, 807\u2013813 (2014).","journal-title":"Dig. Dis. Sci."},{"key":"83232_CR62","doi-asserted-by":"publisher","first-page":"199","DOI":"10.7326\/0003-4819-143-3-200508020-00006","volume":"143","author":"H Hampel","year":"2005","unstructured":"Hampel, H., Abraham, N. S. & El-Serag, H. B. Meta-analysis: Obesity and the risk for gastroesophageal reflux disease and its complications. Ann. Intern. Med. 143, 199\u2013211 (2005).","journal-title":"Ann. Intern. Med."},{"key":"83232_CR63","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1136\/jech-2020-214401","volume":"74","author":"C Bambra","year":"2020","unstructured":"Bambra, C., Riordan, R., Ford, J. & Matthews, F. The COVID-19 pandemic and health inequalities. J. Epidemiol. Community Health. 74, 964\u2013968. https:\/\/doi.org\/10.1136\/jech-2020-214401 (2020).","journal-title":"J. Epidemiol. Community Health"},{"key":"83232_CR64","doi-asserted-by":"publisher","unstructured":"Ambrose, A. J. H. Inequities during COVID-19. Pediatrics 146 https:\/\/doi.org\/10.1542\/peds.2020-1501 (2020).","DOI":"10.1542\/peds.2020-1501"},{"key":"83232_CR65","doi-asserted-by":"publisher","first-page":"e193","DOI":"10.1017\/dmp.2022.104","volume":"17","author":"WS Brakefield","year":"2022","unstructured":"Brakefield, W. S., Olusanya, O. A., White, B. & Shaban-Nejad, A. Social determinants and indicators of COVID-19 among marginalized communities: A scientific review and call to action for pandemic response and recovery. Disaster Med. Public. Health Prep. 17, e193. https:\/\/doi.org\/10.1017\/dmp.2022.104 (2022).","journal-title":"Disaster Med. Public. Health Prep"},{"issue":"13","key":"83232_CR66","doi-asserted-by":"publisher","first-page":"2683","DOI":"10.1084\/jem.2014062511242014c.)","volume":"211","author":"J Wang","year":"2014","unstructured":"Wang, J. et al. Respiratory influenza virus infection induces intestinal immune injury via microbiota-mediated Th17 cell\u2013dependent inflammation. (J Exp. Med. 211 (13), 2683. https:\/\/doi.org\/10.1084\/jem.2014062511242014c.) (2014).","journal-title":"(J Exp. Med."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-83232-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-83232-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-83232-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,31]],"date-time":"2024-12-31T14:08:28Z","timestamp":1735654108000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-83232-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,30]]},"references-count":66,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["83232"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-83232-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,30]]},"assertion":[{"value":"22 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Consent was waived as this retrospective study was approved by the Einstein-Montefiore Institutional Review Board (#2021\u201313658) with an exemption for informed consent and a HIPAA waiver.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}],"article-number":"31850"}}